Medtronic MDT Deferred Revenue
Deferred Revenue at other companies
Other financials
Where this comes from
Reported directly by Medtronic in its filing.
Tagged under the XBRL concept us-gaap:RevenueRemainingPerformanceObligation.
The source filing: Medtronic’s 10-Q, filed February 24, 2026.
- Filed
- Feb 24, 2026, 4:18 PM EST
- Fiscal quarter
- Q3 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-011107
Remaining performance obligations include goods and services that have not yet been delivered or provided under existing, noncancellable contracts with minimum purchase commitments. At January 23, 2026, the estimated revenue expected to be recognized in future periods related to unsatisfied performance obligations for executed contracts with an original duration of one year or more was approximately $0.4 billion. The Company expects to recognize revenue on the majority of these remaining performance obligations over the next three years.
Item 1. Financial Statements
FAQ
- What is Medtronic's deferred revenue?
- Medtronic (MDT) reported deferred revenue of $400M in Q4 2025.
- How has Medtronic's deferred revenue changed year-over-year?
- Medtronic's deferred revenue decreased by 0.0% year-over-year, from $400M to $400M.
- What does deferred revenue mean?
- Payments received from customers for goods or services to be delivered within one year — recognized as revenue as performance obligations are satisfied.
Ask your AI about Medtronic's deferred revenue.
Connect your AI assistant and compare it to peers, right in your chat.
